CTOs on the Move

Health Union

www.health-union.com

 
Health Union integrates the power of human connection with technology to unite people in the shared experiences of life with chronic health conditions. For almost a decade, Health Union has done the hard work every day to bring people living with chronic conditions together. Through a unique and genuine approach to listening and understanding all aspects of health experiences, Health Union`s open, online communities provide a safe place for people to learn, connect and share. In doing so, social interactions evolve into meaningful health conversations. At the same time, these communities offer healthcare companies countless opportunities to understand how to ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.health-union.com
  • 1218 Chestnut Street 2nd Floor
    Philadelphia, PA USA 19107
  • Phone: 484.985.9715

Executives

Name Title Contact Details
William Rompala
Chief Technology Officer Profile
Brad Derstine
Director, Enterprise Information Technology Systems Profile

Similar Companies

Spectrum Home Health Agency

Spectrum Home Health Agency is a Kansas City, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mobility Center Of Va

Mobility Center Of Va is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kootenai Prosthetics and Orthotics

Kootenai Prosthetics and Orthotics is a Coeur D Alene, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PanOptica

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.

Tampa YMCA

The Y is a leading nonprofit committed to strengthening community through youth development, healthy living, and social responsibility.